Dr. Key discusses the role of (hyper) fibrinolysis in selected bleeding disorders including trauma, thrombocytopenia, and heavy menstrual bleeding. He reviews the physiology of fibrinolysis and discuss why it has been challenging to incorporate global assays of fibrinolysis into clinical practice. Finally, he discusses how a greater understanding of the successes and failures of antifibrinolytic agents in clinical trials help to inform the contribution of fibrinolysis in acquired bleeding disorders.
Q&A in third video of playlist.